Martin Delaney Collaboratories for HIV Cure Research (UM1)

Funding Agency:
National Institutes of Health

The purpose of this Funding Opportunity Announcement (FOA) is to address the problem of HIV persistence in HIV-infected persons treated with suppressive antiretroviral drug regimens.  This FOA will support coordinated basic, translational, and clinical research focused on developing strategies to achieve an HIV cure, defined as sustained HIV remission and/or eradication.  The application must include at least one private sector entity to facilitate rapid translation of basic discovery research into clinical studies.  Collaboratory research should be milestone-based and centered on specific innovative approaches spanning characterization and quantification of latent or persistent HIV-1 reservoirs, identification of therapeutic strategies that target these reservoirs and/or control viral rebound, and preclinical and clinical studies to test new single or combination strategies for an HIV cure. 

Deadlines:

  • Letter of Intent Due Date(s): November 7, 2015 
  • Application Due Date(s): December 7, 2015, by 5:00 PM local time of applicant organization.
  • AIDS Application Due Date(s): December 7, 2015, by 5:00 PM local time of applicant organization.

RFA-AI-15-029 Expiration Date December 8, 2015
 

Agency Website

Amount

$17,500,000

Amount Description

Application budgets are limited to $3.5 million Direct Costs per year, and should reflect the actual needs of the proposed project.

The total project period may not exceed 5 years.

Funding Type

Grant

Eligibility

Faculty

Category

Medical - Basic Science
Medical - Clinical Science
Medical - Translational
Medical

External Deadline

December 7, 2015